03/14/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
7:02 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
3:02 PM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
7:37 PM | Cooper Simon Peter (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
7:38 PM | Keros Therapeutics (Issuer)
Rovaldi Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/15/2024
7:40 PM | Keros Therapeutics (Issuer)
Regnante Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
7:41 PM | Keros Therapeutics (Issuer)
Seehra Jasbir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
5:38 PM | ALKEON CAPITAL MANAGEMENT LLC (Filed by)
Keros Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
8:16 AM | FMR LLC (Filed by)
Keros Therapeutics (Subject)
| Form SC 13G/A | |
01/26/2024
4:26 PM | BlackRock Inc. (Filed by)
Keros Therapeutics (Subject)
| Form SC 13G/A | |
01/09/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
3:43 PM | Keros Therapeutics (Issuer)
Regnante Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:02 PM | Keros Therapeutics (Filer)
| Form 424B5 | |
01/04/2024
3:04 PM | Keros Therapeutics (Subject)
Regnante Keith (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
3:04 PM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
7:04 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2023
4:20 PM | Keros Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
12/11/2023
5:44 PM | Keros Therapeutics (Subject)
ORBIMED CAPITAL LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023
5:02 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
7:06 AM | Keros Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023
7:11 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2023
7:02 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2023
7:00 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2023
7:04 AM | Keros Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/24/2023
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2023
5:02 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2023
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2023
8:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2023
3:44 PM | Keros Therapeutics (Issuer)
Seth Alpna (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
